While at the early stage, the 3D Printing industry
is full of exciting promises in terms productivity, healthcare, performance,
flexibility and more.
Among others dynamics, we can note rigorous regulatory guidelines for the approval of 3D-printed
medical devices, high cost of 3D printing systems and 3D-printed organs &
tissues, and scarcity of skilled professionals.
Others challenges include: the process control and understanding of 3D printing technique.
According to Research and Markets, the market is poised to grow at a CAGR of 25.3%
from 2015 to 2020, to reach USD 2.13 Billion by 2020.
Research and Markets reveals that, due to the increasing efforts by leading market
players to expand their distribution networks in the Asian countries, rising
awareness regarding the benefits of 3D printing technology, and presence of a
large patient population, The Asia-Pacific market is expected to grow at the
highest CAGR of 28.2% from 2015 to 2020.
One can also learn from Research and Markets that, new product launches
and product enhancements are the primary growth strategies adopted by major
players to develop their positions in the global 3D printing medical devices
market.
Strategies such as partnerships, agreements, and collaborations;
expansions; and acquisitions were also adopted by a significant number of
market players to strengthen their product portfolios and expand their
geographic presence in the market.